Marketing-authorisation holder
Baxter Corporation
363 medicines in 1 country, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
363 medicines in 1 country, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 363
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION50 mg / ml + 4 mg / ml · Solution | Dextrose, Lidocaine | Canada | Marketed | 1990 |
| 0.9% SODIUM CHLORIDE INJECTION, USP900 mg / 100 ml · Solution | Sodium chloride | Canada | Marketed | 1982 |
| 0.9% SODIUM CHLORIDE IRRIGATION, USP900 mg / 100 ml · Solution | Sodium chloride | Canada | Marketed | 1989 |
| 10% DEXTROSE INJECTION, USP10 g / 100 ml · Solution | Dextrose | Canada | Marketed | 1997 |
| 12% SODIUM CHLORDIE PROCESSING SOLUTION12 g / 100 ml · Solution | Sodium chloride | Canada | Marketed | 1991 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 150 mg / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Marketed | 1978 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 900 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Marketed | 1990 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP5 g / 100 ml + 150 mg / 100 ml · Solution | Dextrose, Potassium chloride | Canada | Marketed | 1989 |
| 20% PROSOL2.76 g / 100 ml + 1.96 g / 100 ml + 0.76 g / 100 ml + 1.02 g / 100 ml + 2.06 g / 100 ml + 1.18 g / 100 ml + 1.08 g / 100 ml + 0.6 g / 100 ml + 1.08 g / 100 ml + 1.35 g / 100 ml + 1 g / 100 ml + 1.34 g / 100 ml + 1.02 g / 100 ml + 0.98 g / 100 ml + 0.32 g / 100 ml + 0.05 g / 100 ml + 1.44 g / 100 ml · Liquid | Alanine, Arginine, Dl-methionine, Glutamic acid, Glycine, Histidine, Isoleucine, L-aspartic acid, Amino acids, Lysine, Phenylalanine, Proline, Serine, Threonine, Tryptophan, Tyrosine, Valine | Canada | Marketed | 1996 |
| 20% SODIUM CHLORIDE INJECTION, BP20 % / w/v · Solution | Sodium chloride | Canada | Marketed | 2022 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP150 mg / 100 ml + 900 mg / 100 ml · Solution | Potassium chloride, Sodium chloride | Canada | Marketed | 1989 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 450 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Marketed | 1989 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP300 mg / 100 ml + 900 mg / 100 ml · Liquid | Potassium chloride, Sodium chloride | Canada | Marketed | 1989 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP5 g / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride | Canada | Marketed | 1989 |
| (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 300 mg / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Marketed | 1978 |
| (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 300 mg / 100 ml + 450 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Marketed | 1989 |
| 5% DEXTROSE INJECTION, USP5 g / 100 ml · Solution | Dextrose | Canada | Marketed | 1990 |
| 70% DEXTROSE INJECTION USP70 g / 100 ml · Solution | Dextrose | Canada | Marketed | 1995 |
| ACETAMINOPHEN INJECTION10 mg / ml · Solution | Paracetamol | Canada | Marketed | 2023 |
| ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML4 g / 100 ml · Solution | Sodium citrate | Canada | Marketed | 1990 |
| ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP4 g / 100 ml · Solution | Sodium citrate dihydrate | Canada | Marketed | 2012 |
| ARTISS3000 kiu / ml + 40 mcmol / ml + 125 mg / ml + 4 unit / ml · Solution | Aprotinin, Calcium chloride, Sealer protein, Thrombin | Canada | Marketed | 2011 |
| AXBERI40 mg / 0.4 ml · Solution | Enoxaparin | Canada | Marketed | 2024 |
| AXBERI30 mg / 0.3 ml · Solution | Enoxaparin | Canada | Marketed | 2024 |
| AXBERI60 mg / 0.6 ml · Solution | Enoxaparin | Canada | Marketed | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 363 | 140 | 223 | CompaniesAll medicines |
Also in the registers of Saudi Arabia
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.